Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29,067,614
-
Total 13F shares
-
16,287,424
-
Share change
-
-128,789
-
Total reported value
-
$850,358,590
-
Put/Call ratio
-
54%
-
Price per share
-
$52.21
-
Number of holders
-
112
-
Value change
-
-$12,114,445
-
Number of buys
-
55
-
Number of sells
-
42
Institutional Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q3 2021
As of 30 Sep 2021,
Krystal Biotech, Inc. - COMMON STOCK (KRYS) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,287,424 shares.
The largest 10 holders included
Redmile Group, LLC, FMR LLC, BlackRock Inc., LORD, ABBETT & CO. LLC, VANGUARD GROUP INC, CREDIT SUISSE AG/, FRAZIER MANAGEMENT LLC, STATE STREET CORP, PICTET ASSET MANAGEMENT SA, and First Light Asset Management, LLC.
This page lists
112
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.